eXoZymes' CCO to Present NCT Solution at MISTA Symposium

Damien Perriman will discuss scaling production of naturally occurring small molecule with metabolic health benefits.

Mar. 14, 2026 at 12:18am

Got story updates? Submit your updates here. ›

eXoZymes Inc., a pioneer of AI-enhanced enzymes, announced that Chief Commercial Officer Damien Perriman will present a solution for scaling production of NCT, a naturally occurring small molecule the company is developing for nutraceutical and pharmaceutical applications. The presentation at next week's MISTA Symposium Healthspan event in San Francisco will focus on NCT's potential role in metabolic health and its emerging relevance in the food, supplements, and longevity-focused wellness solutions market.

Why it matters

NCT is a rare natural compound that has attracted growing attention for its potential metabolic benefits, but its scarcity in nature has limited broader development and commercial exploration. eXoZymes' proprietary exozyme platform aims to enable efficient production of NCT and related compounds, unlocking scalable supply and new opportunities across nutraceutical, pharmaceutical, and specialty ingredient markets.

The details

By leveraging its exozyme platform, eXoZymes is working to produce NCT using AI-designed enzyme cascades operating outside living cells. This approach could overcome the scaling bottleneck that has hampered commercial success in synthetic biology, making exozymes the next generation of biomanufacturing.

  • The MISTA Symposium Healthspan event will take place on March 18, 2026 in San Francisco.

The players

Damien Perriman

Chief Commercial Officer of eXoZymes Inc.

eXoZymes Inc.

A pioneer of AI-enhanced enzymes that transforms abundant feedstock into valuable nutraceuticals and novel medicines.

Got photos? Submit your photos here. ›

What they’re saying

“When it comes to health, a lot of people feel frustrated because they're trying - but nothing seems to work. They feel trapped between conflicting advice and solutions that are difficult to sustain. But now there's hope - what makes NCT so exciting is that it focuses on the underlying problem: how the body converts fuel into energy. By addressing that fundamental process, we believe it could represent a meaningful new approach to metabolic health.”

— Damien Perriman, Chief Commercial Officer of eXoZymes

What’s next

The company believes its approach could unlock a scalable supply of NCT and related compounds, opening new opportunities across nutraceutical, pharmaceutical, and specialty ingredient markets.

The takeaway

eXoZymes' exozyme platform aims to overcome the scaling challenges that have limited commercial success of synthetic biology, potentially enabling efficient production of rare natural compounds like NCT and unlocking new possibilities in metabolic health and wellness solutions.